Genome-wide mapping studies have provided evidence of a type 1 diabetes susceptibility gene (IDDM8) that is located on chromosome 6q27. However, association studies of IDDM8 have so far been negative. The purpose of this investigation was to determine a linkage disequilibrium (LD) map in the chromosome 6q27 region and to better localize IDDM8. A physical map of nearly 1 Mb containing the chromosome 6 telomere was constructed, and polymorphic markers spanning this region were defined. Haplotypes composed of the markers in LD were tested for association with type 1 diabetes in 266 families. A microsatellite marker allele and multiple haplotypes were associated with IDDM8, which suggests localization of this type 1 diabetes susceptibility gene to the terminal 200 kb of chromosome 6.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2337/diabetes.49.3.508 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Exploring treatment-driven subclonal evolution of prognostic triple biomarkers: Dual gene fusions and chimeric RNA variants in novel subtypes of acute myeloid leukemia patients with KMT2A rearrangement.
Drug Resist Updat
January 2025
Loma Linda University Cancer Center, Loma Linda, CA 92354, United States; Department of Basic Sciences, Loma Linda University, Loma Linda, CA 92354, United States. Electronic address:
Chromosomal rearrangements (CR) initiate leukemogenesis in approximately 50 % of acute myeloid leukemia (AML) patients; however, limited targeted therapies exist due to a lack of accurate molecular and genetic biomarkers of refractory mechanisms during treatment. Here, we investigated the pathological landscape of treatment resistance and relapse in 16 CR-AML patients by monitoring cytogenetic, RNAseq, and genome-wide changes among newly diagnosed, refractory, and relapsed AML. First, in FISH-diagnosed KMT2A (MLL gene, 11q23)/AFDN (AF6, 6q27)-rearrangement, RNA-sequencing identified an unknown CCDC32 (15q15.
View Article and Find Full Text PDFGenomic profiles and clinical presentation of chordoma.
Acta Neuropathol Commun
August 2024
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Article Synopsis
- Chordoma is a rare bone cancer affecting mainly adults, with an average diagnosis age of 45.5 years; it is most commonly found in the clivus, spinal column, and sacrum.
- A large majority of patients (97.5%) underwent surgery, and many also received supplementary treatments; however, no significant cancer types appeared frequently among patients' families aside from the most common cancers.
- Genomic analysis of tumor samples revealed recurrent mutations, notably in PIK3CA, and differences in genetic alterations based on the tumor location, indicating a complex relationship between tumor genetics and clinical outcomes.
Generation of two isogenic patient-derived human-induced pluripotent stem cell clones with 6q27 deletion.
Stem Cell Res
October 2024
Developmental Origins of Pediatric Cancer Junior Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany. Electronic address:
We generated two human induced pluripotent cell (hiPSC) isogenic clones from an 11-year-old patient with 6q27 deletion syndrome. The heterozygous deletion encompasses approximately 240 kilobases, affecting 6 genes (promoter region of WDR27, coding regions of C6orf120, PHF10, DYNLT2, ERMARD, LINC00242). The patient suffered from epilepsy, psychosocial retardation, and a metabolic disorder.
View Article and Find Full Text PDFClinical features associated with maternal uniparental disomy for chromosome 6.
Mol Cytogenet
July 2024
Department of Endocrinology, the Children's Hospital of Zhejiang University School of Medicine, No 3333 Binsheng Road, Hangzhou, 310052, China.
Article Synopsis
- Maternal uniparental disomy for chromosome 6 (upd) is linked to intrauterine growth restriction (IUGR), but the exact clinical details are not well defined.
- Two new cases were analyzed, one showing mixed isodisomy and heterodisomy patterns, and the other having a homozygous mutation in SCUBE3 along with maternal upd.
- Of the 21 documented cases of maternal upd, 85.7% experienced IUGR, highlighting a significant correlation between this genetic condition and growth issues in utero.
Novel liquid biopsy CNV biomarkers in malignant melanoma.
Sci Rep
July 2024
Department of Molecular Biology and Genomics, Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin (JFM CU), Martin, Slovakia.
Article Synopsis
- Malignant melanoma (MM) has numerous genetic changes and a quick spread, making it important to find new plasma biomarkers for easier diagnosis and monitoring.
- The study investigated copy number variations (CNVs) in CDK genes and other specific genes through various genetic analyses, but found that CDK genes were not significant as biomarkers in plasma samples of MM patients compared to healthy individuals.
- Despite the lack of significance for CDK genes, the analysis did identify common CNV regions in the genome, suggesting that the gene DIP2C could be promising for further research in liquid biopsy applications.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!